Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on visible light photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107417615A enables visible light promoted synthesis of chiral quinolinone derivatives. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN115232164B enables efficient sulfonyl thiophosphate production via visible light photocatalysis. Offers cost reduction and supply chain reliability for agrochemical intermediates.
Patent CN111848628A reveals a green g-C3N4 catalyzed route for high-purity intermediates, offering significant cost reduction and supply chain reliability for global API manufacturers.
Novel visible-light method using 4CzIPN for high-purity sulfone intermediates. Reduces cost and simplifies supply chain for pharma manufacturing.
Patent CN112279754B reveals a mild blue-light photocatalytic route for fluorinated sesquiterpenes, offering cost-effective scaling for pharmaceutical intermediates.
Patent CN115043846B details a visible-light catalyzed route for pyrroloindole derivatives, offering scalable manufacturing and cost-effective pharmaceutical intermediate production.
Patent CN113292633B enables catalyst-free visible light hydrazine modification. Offers high purity unnatural amino acids with reduced manufacturing costs and scalable supply chain reliability.
Patent CN114835660A reveals a metal-free, visible-light mediated method for oxime ether synthesis, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114773284B details a visible light-mediated synthesis of dihydroisoxazoles using terminal olefins. Offers mild conditions and cost-effective raw materials for pharmaceutical intermediates.
Patent CN110759836B reveals a metal-free fluoroalkylation method using acetone and visible light, offering cost-effective synthesis for high-purity pharmaceutical intermediates.
Patent CN113461617A reveals a metal-free visible light method for N-heterocycles. Offers cost reduction and high purity for pharmaceutical intermediate manufacturing supply chains.
Patent CN110981676A discloses a metal-free visible light method for beta-ketosulfones. Offers cost reduction and green manufacturing for pharmaceutical intermediates.
Novel metal-free decarboxylative ketonization method offers cost-effective, scalable production of high-purity pharmaceutical intermediates with green chemistry advantages.
Patent CN112390755B enables mild heteroarylation of amines using visible light. This breakthrough offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Patent CN105130898A enables visible-light synthesis of gem-difluoro polycyclic compounds. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN118125897A reveals a room-temperature visible-light method for Z-selective monofluoroolefin synthesis, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN108623494B details a green photocatalytic method for synthesizing imines using sulfur-containing aza metalloporphyrin, offering high selectivity and cost reduction.
Patent CN105985290B reveals oxidant-free visible light photocatalysis for isoquinoline derivatives. This method ensures high purity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN113121338A reveals a green photocatalytic method for alpha-hydroxylation using air and visible light, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111961011B reveals a metal-free visible light method for benzothiazole derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.